Trade Name | Drug Name | Approved | Patent Expires | Indication |
---|---|---|---|---|
Crysvita | Burosumab | 2018-04-17 | ||
Fareston | Toremifene | 1997-05-29 | ||
Moventig | Naloxegol | 2014-12-07 | 2024-2032 | |
Nourianz | Istradefylline | 2019-08-27 | 2023-2027 | |
Pecfent | Fentanyl | 2010-08-31 | 2024-2033 | |
Poteligeo | Mogamulizumab | 2018-08-08 | ||
Sancuso | Granisetron | 2012-04-20 | 2024-2025 |
Drug Name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Indication |
---|---|---|---|---|---|